News
The vaccination campaign against COVID-19 - will start in Ukraine on February, 24 - Maksym Stepanov24 February 2021The Minister of Health Maxim Stepanov informed that Ukraine is provided with vaccines for the first and second stages of vaccination, which begins on February 24. "Already today, the first batches of the vaccine went to the regions. The first stage will be held in a short time. All healthcare workers should receive the maximum level of protection, "the minister said, adding that the CoviShield vaccine (Oxford / AstraZeneca) has been approved by the World Health Organization. The head of the department also said that during his visit to India he held talks on increasing the supply of the American vaccine to NovaVax by 5 million doses. The expected amount will be about 15 million doses. In particular, vaccines are currently expected to be delivered from: global initiative Covax - 117 thousand doses, Sinovac - about 2.5 million doses, Novavax - 10 million doses (increased by 5 million doses of the vaccine as agreed). |
Happy Pharmacist Day!18 September 2020On the third Saturday of September, congratulations on the occasion of the professional holiday are traditionally received by pharmaceutical workers. |
The information is intended for healthcare professionals.2 July 2020Understanding the paramount importance of the incidence of tuberculosis in Ukraine, Lumiere Pharma LLC, as a domestic socially responsible company, introduced the production of the drug PPD RT 23 SSI, injection solution 2 TO / 0.1 ml, 1.5 ml in a bottle No. 1 complete with 15 self-locking syringes with in bulk mold from a global vaccine manufacturer AJ Vaccines AE / Denmark, Denmark. Tuberculin PPD RT 23 SSI is supplied in a set 1 bottle of 1.5 ml injection solution containing 15 doses (2 TO / 0.1 ml) of PPD RT 23 SSI with 15 self-locking syringes. The advantages of the drug PPD RT 23 SSI: 1. Injection single-dose self-locking syringes and a bottle with a chlorobutyl stopper with a patented polypropylene “flip-off” cap allow 15 intradermal tuberculin samples of Mantoux to be taken without loss (leakage) of half of the purchased drug, that is, to perform one Mantoux test, only one syringe must be filled with a self-locking syringe dose (0.1 ml) of the drug PPD RT 23 SSI. 2. Injectable self-locking syringe with a spring clip have a scale of 0.1 ml, designed for tuberculin diagnostics and nested 15 pieces in each tuberculin package. Each syringe has an integrated (unearthly) needle with an intradermal section, which allows you to collect only one dose (0.1 ml) of tuberculin, necessary for the Mantoux test. After the introduction of tuberculin, the spring retainer blocks the movement of the piston, which makes it impossible to use it further. 3. Storage conditions for the RT 23 SSI PPD for 24 hours after opening the vial at a temperature of 2 + 8 ° С allow effective use of tuberculin in full (without leakage of doses) for two shifts in the vaccination rooms of the CPMSD. All of the above makes it possible to more effectively diagnose the incidence of tuberculosis and leads to a decrease in the financial burden on healthcare institutions in Ukraine and significant savings in public funds. |
Happy Pharmaceutical Day of Ukraine25 September 2019Pharmacists are true magicians, because they can not only pronounce "acetylsalicylic acid", but also read everything that doctors write to us in their indiscriminate handwriting. Even more! They know about all the drug components, contraindications and analogues. At present, over 350 thousand people work in the pharmaceutical industry of Ukraine. Accept the sincere wishes of good health, well-being, happiness and goodness, warmth and love, family harmony and well-being. May every day give you creative inspiration, stability in pharmaceutical activity, successful problem solving! May fate always smile on you, and people give sincere thanks for your kindness and professionalism! |
LUMIER PHARM LLC successfully delivered BLOOTSIN-C, lyophilisate for solution for injection, 15000 IU per vial, No. 1 to international organizations of UNDP and Crown Agents within the tenders of the Ministry of Health budget11 September 2019According to the Resolution of the Cabinet of Ministers of Ukraine of March 13, 2019 No. 255 “On Approving the List of Medicines and Medical Devices Purchased under Purchase Agreements with Specialized Organizations Performing Procurement by Budget Purposes in 2019 under the Provision Program medical measures of individual state programs and complex measures of a programmatic character ”», namely by programs: - Chemotherapeutic drugs, radiopharmaceuticals and accompanying preparations for the treatment of cancer patients: Drugs for the treatment of cancer patients; Medicines for patients suffering from onco-hematological diseases; - Medicines and medical products for the treatment of children suffering from cancer and oncohematological diseases. LUMIER PHARM LLC successfully delivered BLOOTSIN-C, lyophilisate for solution for injection, 15000 IU per bottle, No. 1 to the international organizations of UNDP and Crown Agents within the tenders conducted by the Ministry of Health. |
LUMIER PHARM LLC celebrates 10 years of success28 August 2019The history of the company is a success story with ups and downs, but always in a sustainable development, with great ambitions and continuous improvement. Over the decades, LUMIER PHARM has established a reputation as a reliable partner, as it has always been one of the basic principles of the company to always fulfill its obligations under any circumstances. LUMIER PHARM LLC successfully cooperated with companies such as F.Hoffmann-La Roche Ltd; MSD; AJ Vaccines A / S; Nippon Kayaku Co., Ltd and others. The priority activity of the company remains providing the Ukrainian population with vital prescription drugs for the treatment of cancer, tuberculosis, blood diseases, chronic viral hepatitis. |
Charity event for the transmission of five medical vacuum suction pumps7 June 2019On June 05, 2019, with the assistance of NGO "Ukrainian League for Palliative and Hospice Care" and LLC "LUMIER FARM", a charity event was held at the Kyiv Palliative Care Center for the transfer of five medical vacuum suction pumps with battery life for Ambu the Mobile Brigade Center. The event was attended by the League's Executive Director Tomash V.V., Deputy Director of LLC "LUMIER PHARM" M.M. Pertsovych, Head of the NGO "Ukrainian League for Palliative and Hospice Care" in Kyiv Zachek L.M., Chief physician of KMKShVL Chubar OV and Head of the Ambulatory Mobile Brigade Trofimov I.P. |
We sincerely congratulate you on the bright resurrection of Christ!7 April 2019Dear friends, colleagues! We sincerely congratulate you on the bright resurrection of Christ! This holiday again and again brings us back to eternal values - mercy and love for our neighbor, to the belief in the victory of light over darkness. Today we gratefully pray for everyone who keeps our peace on Easter night and who stands guard of peace on the feast day. May Easter bring to the house of every Ukrainian a concord, give hope and strengthen faith. We wish you happiness, good health, warm heart and God's blessing! Christ is Risen! |
Happy 2019 New Year31 December 2018New Year is a time of realization of desires, hopes and bright impressions! We wish these charming feelings did not leave you all this coming year! Along with its new symbol - the Yellow Earth Pig - joy, comfort and fairytale love are tapped into your home by the chimes. |
LLC "LUMIER PHARMA" successfully delivered the drug "BLEOCIN-C, lyophilisate for preparation of solution for injection, at 15000 IU in a bottle, № 1"26 December 2018According to the Resolution of the Cabinet of Ministers of Ukraine of March 28, 2018 No. 278 “On approval of the list of medicines and medical devices purchased on the basis of procurement agreements with specialized organizations that procure by directions of use of budget funds in 2018 under the program“ Provision medical measures of individual state programs and complex measures of a programmatic character ”», namely by programs: - Chemotherapeutic drugs, radiopharmaceuticals and accompanying preparations for the treatment of cancer patients: Drugs for the treatment of cancer patients; Medicines for patients suffering from onco-hematological diseases; - Medicines and medical products for the treatment of children suffering from cancer and oncohematological diseases. LUMIER PHARM LLC successfully delivered BLOOTSIN-C, lyophilisate for solution for injection, 15000 IU per bottle, No. 1 to the international organizations of UNDP and Crown Agents within the tenders conducted by the Ministry of Health. |
| Pages: | 1 | 2 | 3 | 4 |  |
 |
© 2008 - 2012 Lumier Pharma. All rights reserved.
© 2012 made by mc design
mc design - Creative Design Lab
© 2012 made by mc design